Gene therapy could restore sight in progressive blindness
NCT ID NCT04278131
First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a gene therapy called BS01 for people with retinitis pigmentosa, a genetic condition that causes gradual vision loss. The therapy uses a harmless virus to deliver a light-sensitive protein to remaining eye cells, aiming to help them detect light again. The trial will enroll 20 participants and focus on safety, as well as improvements in detecting light, motion, and objects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
New Jersey Retina
RECRUITINGTeaneck, New Jersey, 07666, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.